Presenting Companies
Listed below are the companies selected to present at the BIO CEO & Investor Conference.
The list is subject to change and will be updated periodically as selected companies confirm their presentations.
30-Minute Company Presentations (Click here for focus session presenters)
ACADIA Pharmaceuticals (NASDAQ : ACAD)
Acusphere, Inc. (NASDAQ : ACUS)
ADVENTRX Pharmaceuticals, Inc. (AMEX : ANX)
Ęterna Zentaris Inc. (TSX : AEZ)
Albany Molecular Research, Inc. (NASDAQ : AMRI)
Alkermes, Inc. (NASDAQ : ALKS)
Allos Therapeutics, Inc. (NASDAQ : ALTH)
Alnylam Pharmaceuticals (NASDAQ : ALNY)
Anadys Pharmaceuticals, Inc. (NASDAQ : ANDS)
AnGes MG, Inc. (Mothers Tokyo : 4563)
Arena Pharmaceuticals (NASDAQ : ARNA)
Array BioPharma (NASDAQ : ARRY)
Avalon Pharmaceuticals, Inc. (NASDAQ : AVRX)
AVANT Immunotherapeutics, Inc. (NASDAQ : AVAN)
Avigen, Inc. (NASDAQ : AVGN)
Axonyx, Inc. (NASDAQ : AXYX)
BioCryst Pharmaceuticals, Inc. (NASDAQ : BCRX)
BioMS Medical Corp. (TSX : MS)
Bionovo, Inc. (OCT : BNVI)
Callisto Pharmaceuticals, Inc. (AMEX : KAL)
CancerVax Corporation (NASDAQ : CNVX)
Celera Genomics Group (NYSE : CRA)
Celgene Corporation (NASDAQ : CELG)
Cell Genesys, Inc. (NASDAQ : CEGE)
Cell Therapeutics, Inc. (NASDAQ : CTIC)
CombinatoRx, Incorporated (NASDAQ : CRXX)
Compugen (NASDAQ : CGEN)
Corgentech, Inc. (NASDAQ : CGTK)
Critical Therapeutics, Inc. (NASDAQ : CRTX)
Cubist Pharmaceuticals, Inc. (NASDAQ : CBST)
CuraGen Corporation (NASDAQ : CRGN)
Curis, Inc. (NASDAQ : CRIS)
Cyberkinetics Neurotechnology Systems Inc. (OTC BB : CYKN.OB)
Cytogen Corporation (NASDAQ : CYTO)
Cytokinetics, Inc. (NASDAQ : CYTK)
CytRx Corporation (NASDAQ : CYTR)
deCODE genetics Inc. (NASDAQ : DCGN)
Discovery Laboratories, Inc. (NASDAQ : DSCO)
Diversa Corporation (NASDAQ : DVSA)
DOV Pharmaceutical, Inc. (NASDAQ : DOVP)
DuPont (NASDAQ : DD)
DURECT Corporation (NASDAQ : DRRX)
Dyadic International, Inc. (AMEX : DIL)
Dyax Corp. (NASDAQ : DYAX)
Emisphere Technologies, Inc. (NASDAQ : EMIS)
Encysive Pharmaceuticals Inc. (NASDAQ : ENCY)
EntreMed, Inc. (NASDAQ : ENMD)
Evotec AG (Frankfurt Stock Exchange : EVT)
Forbes Medi-Tech Inc. (NASDAQ : FMTI)
Genomic Health (NASDAQ : GHDX)
Genta Incorporated (NASDAQ : GNTA)
Geron Corporation (NASDAQ : GERN)
GPC Biotech AG (Frankfurt : GPC)
Hana Biosciences, Inc. (AMEX : HBX)
Human Genome Sciences, Inc. (NASDAQ : HGSI)
IBEX Technologies (TSX : IBT)
Icagen, Inc. (NASDAQ : ICGN)
Idenix Pharmaceuticals, Inc. (NASDAQ : IDIX)
IDM Pharma, Inc. (NASDAQ : IDMI)
ImmunoGen, Inc. (NASDAQ : IMGN)
Inhibitex, Inc. (NASDAQ : INHX)
InNexus Biotechnology Inc. (TSX Venture : IXS)
Inovio Biomedical Corporation (AMEX : INO)
Isis Pharmaceuticals, Inc. (NASDAQ : ISIS)
Keryx Biopharmaceuticals, Inc. (NASDAQ : KERX)
La Jolla Pharmaceutical Company (NASDAQ : LJPC)
Marshall Edwards Inc (NASDAQ : MSHL)
Maxygen, Inc. (NASDAQ : MAXY)
Medarex, Inc. (NASDAQ : MEDX)
Medicure Inc. (TSX : MPH)
MediGene AG (OTC : MDGEF.PK)
Metabasis Therapeutics, Inc. (NASDAQ : MBRX)
MethylGene Inc. (TSX : MYG.TO)
MGI PHARMA, INC. (NASDAQ : MOGN)
Momenta Pharmaceuticals, Inc. (NASDAQ : MNTA)
Monsanto Company (NYSE : MON)
MorphoSys AG (Frankfurt : MOR.ETR)
Nabi Biopharmaceuticals (NASDAQ : NABI)
Nastech Pharmaceutical Company Inc. (NASDAQ : NSTK)
Nektar Therapeutics (NASDAQ : NKTR)
Neose Technologies, Inc. (NASDAQ : NTEC)
Neurogen Corporation (NASDAQ : NRGN)
NitroMed Inc. (NASDAQ : NTMD)
Northfield Laboratories Inc. (NASDAQ : NFLD)
Novadel Pharma (AMEX : NVD)
Novavax, inc. (Nasdaq : NVAX)
Nuvelo, Inc. (NASDAQ : NUVO)
Oncolytics Biotech Inc. (TSX : ONC)
OrthoLogic Corp. (NASDAQ : OLGC)
Oscient Pharmaceuticals (NASDAQ : OSCI)
Panacos Pharmaceuticals, Inc. (NASDAQ : PANC)
Peplin Limited (ASX : PEP)
Peregrine Pharmaceuticals, Inc. (NASDAQ : PPHM)
Pharmaxis Ltd (NASDAQ : PXSL)
Rigel Pharmaceuticals, inc. (NASDAQ : RIGL)
Sangamo BioSciences, Inc. (NASDAQ : SGMO)
Seattle Genetics, Inc. (NASDAQ : SGEN)
SemBioSys Genetics Inc. (TSX : SBS.TO)
Sirna Therapeutics, Inc. (NASDAQ : RNAI)
Sosei Co. Ltd. (Mothers Tokyo : 4565)
Spectrum Pharmaceuticals, Inc. (NASDAQ : SPPI)
Sunesis Pharmaceuticals, Inc. (Nasdaq : SNSS)
SuperGen, Inc. (NASDAQ : SUPG)
Tanox (NASDAQ : TNOX)
Targeted Genetics Corporation (NASDAQ : TGEN)
Threshold Pharmaceuticals (NASDAQ : THLD)
Vasogen Inc. (NASDAQ : VSGN)
VaxGen, Inc. (OTC : VXGN.PK)
Vernalis PLC (LSE : VER)
Vertex Pharmaceuticals Incorporated (NASDAQ : VRTX)
VioQuest Pharmaceuticals (OTCBB : VQPH)
VIVUS Inc. (NASDAQ : VVUS)
XOMA Ltd. (Nasdaq : xoma)
Zonagen (NASDAQ : ZONA)
ZymoGenetics, Inc. (NASDAQ : ZGEN)
Focus Sessions (Click here for 30-minute company presentations)
Acrux Ltd (ASX : ACR)
Adherex Technologies Inc. (TSE : AHX)
Advanced Cell Technology (OTCBB : ACTC)
Alfacell Corporation (NASDAQ : ACEL)
Alizyme (LSE : AZM)
Anadys Pharmaceuticals, Inc. (NASDAQ : ANDS)
Antisoma (LSE : ASM)
ARIAD Pharmaceuticals, Inc. (NASDAQ : ARIA)
Auxilium Pharmaceuticals (NASDAQ : AUXL)
Avalon Pharmaceuticals, Inc. (NASDAQ : AVRX)
AVANT Immunotherapeutics, Inc. (NASDAQ : AVAN)
Bioenvision, Inc. (NASDAQ : BIVN)
Biomira Inc. (Nasdaq : BIOM)
Bionovo, Inc. (OCT : BNVI)
BioSante Pharmaceuticals, Inc. (Amex : BPA)
Cell Genesys, Inc. (NASDAQ : CEGE)
ChemGenex Pharmaceuticals (Nasdaq : CXSP)
Coley Pharmaceutical Group, Inc. (NASDAQ : COLY)
CombinatoRx, Incorporated (NASDAQ : CRXX)
Cytogen Corporation (NASDAQ : CYTO)
Cytokinetics, Inc. (NASDAQ : CYTK)
Cytori Therapeutics (NASDAQ : CYTX)
deCODE genetics Inc. (NASDAQ : DCGN)
Dendreon Corporation (NASDAQ : DNDN)
Evotec AG (Frankfurt Stock Exchange : EVT)
EXACT Sciences Corporation (NASDAQ : EXAS)
Favrille, Inc. (Nasdaq : FVRL)
Genaera Corporation (Nasdaq : GENR)
Genta Incorporated (NASDAQ : GNTA)
GenVec, Inc. (NASDAQ : GNVC)
Geron Corporation (NASDAQ : GERN)
GPC Biotech AG (Frankfurt : GPC)
Idenix Pharmaceuticals, Inc. (NASDAQ : IDIX)
Idera Pharmaceuticals, Inc. (AMEX : IDP)
Insmed Incorporated (Nasdaq : INSM)
Introgen Therapeutics, Inc. (NASDAQ : INGN)
ISTA Pharmaceuticals, Inc. (Nasdaq : ISTA)
Kosan Biosciences, Inc. (NASDAQ : KOSN)
Manhattan Pharmaceuticals, Inc. (AMEX : MHA)
Medarex, Inc. (NASDAQ : MEDX)
Medicure Inc. (TSX : MPH)
Metabolic Pharmaceuticals, Ltd. (ASX (Australia) : MBP)
MIGENIX Inc. (TSX : MGI)
Millennium Pharmaceuticals, Inc. (NASDAQ : MLNM)
Monsanto Company (NYSE : MON)
Neurobiological Technologies, Inc. (NASDAQ : NTII)
Nuvelo, Inc. (NASDAQ : NUVO)
OXiGENE, Inc. (NASDAQ : OXGN)
PAION (XETRA : PA8)
Palatin Technologies, Inc. (AMEX : PTN)
Panacos Pharmaceuticals, Inc. (NASDAQ : PANC)
Pharmacopeia Drug Discovery, Inc. (Nasdaq : PCOP)
Pozen, Inc. (NASDAQ : POZN)
pSivida
SemBioSys Genetics Inc. (TSX : SBS.TO)
Sirna Therapeutics, Inc. (NASDAQ : RNAI)
Sunesis Pharmaceuticals, Inc. (Nasdaq : SNSS)
SuperGen, Inc. (NASDAQ : SUPG)
Tanox (NASDAQ : TNOX)
VaxGen, Inc. (OTC : VXGN.PK)
Vertex Pharmaceuticals Incorporated (NASDAQ : VRTX)
Vical Incorporated (Nasdaq : VICL)